Year |
Citation |
Score |
2023 |
Lehman MK, Sturd NA, Razvi F, Wellems DL, Carson SD, Fey PD. Proline transporters ProT and PutP are required for Staphylococcus aureus infection. Plos Pathogens. 19: e1011098. PMID 36652494 DOI: 10.1371/journal.ppat.1011098 |
0.244 |
|
2020 |
Carson SD, Cole AJ. Albumin enhances the rate at which Coxsackievirus B3 strain 28 converts to A-particle. Journal of Virology. PMID 31915275 DOI: 10.1128/Jvi.01962-19 |
0.403 |
|
2019 |
Lehman MK, Nuxoll AS, Yamada KJ, Kielian T, Carson SD, Fey PD. Protease-Mediated Growth of Staphylococcus aureus on Host Proteins Is Dependent. Mbio. 10. PMID 31040245 DOI: 10.1128/Mbio.02553-18 |
0.273 |
|
2017 |
Carson SD, Tracy S, Kaczmarek ZG, Alhazmi A, Chapman NM. Corrigendum: Three capsid amino acids notably influence coxsackie B3 virus stability. The Journal of General Virology. 98: 126-127. PMID 28218574 DOI: 10.1099/Jgv.0.000732 |
0.307 |
|
2017 |
Carson SD, Hafenstein S, Lee H. MOPS and coxsackievirus B3 stability Virology. 501: 183-187. PMID 27940223 DOI: 10.1016/J.Virol.2016.12.002 |
0.315 |
|
2015 |
Carson SD, Tracy S, Kaczmarek ZG, Alhazmi A, Chapman NM. Three capsid amino acids notably influence coxsackie B3 virus stability. The Journal of General Virology. PMID 26489722 DOI: 10.1099/Jgv.0.000319 |
0.371 |
|
2014 |
Carson SD. Kinetic models for receptor-catalyzed conversion of coxsackievirus B3 to A-particles. Journal of Virology. 88: 11568-75. PMID 25078690 DOI: 10.1128/JVI.01790-14 |
0.282 |
|
2014 |
Organtini LJ, Makhov AM, Conway JF, Hafenstein S, Carson SD. Kinetic and structural analysis of coxsackievirus B3 receptor interactions and formation of the A-particle. Journal of Virology. 88: 5755-65. PMID 24623425 DOI: 10.1128/Jvi.00299-14 |
0.312 |
|
2013 |
Carson SD, Pirruccello SJ. HeLa cell heterogeneity and coxsackievirus B3 cytopathic effect: implications for inter-laboratory reproducibility of results. Journal of Medical Virology. 85: 677-83. PMID 23408555 DOI: 10.1002/jmv.23528 |
0.314 |
|
2011 |
Carson SD, Chapman NM, Hafenstein S, Tracy S. Variations of coxsackievirus B3 capsid primary structure, ligands, and stability are selected for in a coxsackievirus and adenovirus receptor-limited environment. Journal of Virology. 85: 3306-14. PMID 21270163 DOI: 10.1128/Jvi.01827-10 |
0.389 |
|
2010 |
Jacobs AC, Hood I, Boyd KL, Olson PD, Morrison JM, Carson S, Sayood K, Iwen PC, Skaar EP, Dunman PM. Inactivation of phospholipase D diminishes Acinetobacter baumannii pathogenesis. Infection and Immunity. 78: 1952-62. PMID 20194595 DOI: 10.1128/Iai.00889-09 |
0.422 |
|
2009 |
Basma H, Soto-Gutiérrez A, Yannam GR, Liu L, Ito R, Yamamoto T, Ellis E, Carson SD, Sato S, Chen Y, Muirhead D, Navarro-Alvarez N, Wong RJ, Roy-Chowdhury J, Platt JL, et al. Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology. 136: 990-9. PMID 19026649 DOI: 10.1053/j.gastro.2008.10.047 |
0.247 |
|
2007 |
Carson SD, Kim KS, Pirruccello SJ, Tracy S, Chapman NM. Endogenous low-level expression of the coxsackievirus and adenovirus receptor enables coxsackievirus B3 infection of RD cells Journal of General Virology. 88: 3031-3038. PMID 17947527 DOI: 10.1099/Vir.0.82710-0 |
0.4 |
|
2004 |
Drescher KM, Kono K, Bopegamage S, Carson SD, Tracy S. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: Insulitis determines susceptibility of pancreatic islets to virus infection Virology. 329: 381-394. PMID 15518817 DOI: 10.1016/J.Virol.2004.06.049 |
0.296 |
|
2004 |
Carson SD. Coxsackievirus and adenovirus receptor (CAR) is modified and shed in membrane vesicles Biochemistry. 43: 8136-8142. PMID 15209509 DOI: 10.1021/bi049778d |
0.292 |
|
2004 |
Carson SD, Switzer BL, Tracy SM, Chapman NM. Monoclonal Antibody against Mouse CAR following Genetic Immunization Hybridoma and Hybridomics. 23: 19-22. PMID 15000844 DOI: 10.1089/153685904322771980 |
0.295 |
|
2003 |
Cunningham KA, Chapman NM, Carson SD. Caspase-3 activation and ERK phosphorylation during CVB3 infection of cells: influence of the coxsackievirus and adenovirus receptor and engineered variants. Virus Research. 92: 179-86. PMID 12686427 DOI: 10.1016/S0168-1702(03)00044-3 |
0.311 |
|
Show low-probability matches. |